// App-Quantinova.ai

BSH2020‐PO‐098 : Minimal residual disease and the prediction of survival outcomes in chronic lymphocytic leukaemia: a pooled analysis of observational and clinical trial data

Researchers

Presenter

  • E. Ngonga Kemadjou

Principal Investigators

  • R. Johnston

  • A. Martin

Medical Centers

  • JB Medical Limited, Sudbury

  • Medical Affairs Oncology, AbbVie, Maidenhead

  • Crystallise Limited, Basildon, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved